Search General Info
Search Education
Search Partnering Companies
ImmunoChem Therapeutics, LLC
2:00 PM - 2:15 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 104C
![BIO International Convention](/sites/default/files/2021-09/_BIO_CONV_Logo-White.png)
ImmunoChem Therapeutics, a Phase 2 clinical stage, Northwestern University spin-out, is developing two clinical assets targeting abnormal neuroinflammation, a major contributor to cognitive decline in Alzheimer’s disease and other dementias, as well as in brain injury, and stroke.
The development of our experimental drugs was supported by non-dilutive, peer-reviewed grants from the NIH, by the Alzheimer’s Association and by the Alzheimer's Drug Discovery Foundation.
Our most advanced clinical candidate is in an NIH-funded proof-of-concept Phase 2a trial in intracerebral hemorrhage.
Our strategy is to conduct a Phase 2 trial in an orphan CNS disease as a fastest path to market, and then expand into other neurodegenerative diseases, with Alzheimer’s disease being our ultimate goal.
The development of our experimental drugs was supported by non-dilutive, peer-reviewed grants from the NIH, by the Alzheimer’s Association and by the Alzheimer's Drug Discovery Foundation.
Our most advanced clinical candidate is in an NIH-funded proof-of-concept Phase 2a trial in intracerebral hemorrhage.
Our strategy is to conduct a Phase 2 trial in an orphan CNS disease as a fastest path to market, and then expand into other neurodegenerative diseases, with Alzheimer’s disease being our ultimate goal.
![](https://www.abstractscorecard.com/uploads/Tasks/upload/20525/EOISBJNL-1525239-1-JPG.png)
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
MA
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
CNS/Neurological
Lead Product in Development:
MW189
Development Phase of Primary Product:
Phase II
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Two: MW189 and MW151
Speaker
![Placeholder Photo](/act-root/bio/assets/images/speaker-default.png)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved